Compare STE & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STE | MKL |
|---|---|---|
| Founded | 1985 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 24.4B |
| IPO Year | 1992 | 1986 |
| Metric | STE | MKL |
|---|---|---|
| Price | $263.47 | $2,051.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $268.25 | ★ $1,930.50 |
| AVG Volume (30 Days) | ★ 653.3K | 41.6K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 59.39 | N/A |
| EPS | 6.97 | ★ 142.27 |
| Revenue | $5,702,415,000.00 | ★ $16,210,307,000.00 |
| Revenue This Year | $9.24 | N/A |
| Revenue Next Year | $6.30 | $0.39 |
| P/E Ratio | $37.76 | ★ $14.39 |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $200.98 | $1,621.89 |
| 52 Week High | $268.60 | $2,109.91 |
| Indicator | STE | MKL |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 55.39 |
| Support Level | $256.68 | $2,018.46 |
| Resistance Level | $268.60 | $2,063.13 |
| Average True Range (ATR) | 4.64 | 32.67 |
| MACD | -0.69 | -6.09 |
| Stochastic Oscillator | 65.59 | 41.47 |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.